Skip to content
★ Sign in to follow
MI

Medtecs International Corp Ltd Stock: price and insider trades · Singapore

ISIN BMG5958R1043SG·Mcap SGD 64.3M

No insider purchase over the last 90 days. The latest, by WILLIAM YANG WEIYUAN, was filed 23 Aug 2021.

Medtecs International Corp Ltd: what insiders have been doing

Every trade that managers of Medtecs International Corp Ltd disclose to SGX is tracked on this page. The past year has been quiet: not a single insider filing for Medtecs International Corp Ltd. The previous disclosure was published on 10 May 2024.

Over the whole record (from 2020), the tally stands at 7 purchases and 7 sales.

Source: insider filings from SGX. Past trades are no guide to future returns.

Insider Decl.
16
Thresholds
n/a
Buy Volume
€2M
7 ops. · all time
Sell Volume
€9M
7 ops. · all time

Since the insiders bought

  • Filed 23 Aug 2021 · 1903 days ago · €180k
    -68.8%
    Entry SGD 0.56 · Close at T+365 SGD 0.17
  • Filed 04 Sept 2020 · 2256 days ago · €8,347
    -62.5%
    Entry SGD 1.44 · Close at T+365 SGD 0.54

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 25,723 of 26,914 companies
14.7
score / 100
Value
13
Quality
17
FCF yld-14%
Earn yld-7.4%
EV/EBITDA37.6x
ROE-4.3%
Gross mgn16%
Net mgn-6.0%
Debt/EBITDA9.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

SGD 0.12
Analyst consensus
1 analysts
·
SGD 0.13Target SGD 0.13(+8%)SGD 0.13
Income statement
RevenueSGD 79M
Gross profitSGD 12.6M16% margin
EBITDASGD 2.3M3% margin
Net income-SGD 4.8M-5.3% margin
Valuation
P/Book0.5x
Beta0.69
Balance sheet & cash
Market capSGD 64.3M
Total debtSGD 21.7M
Free Cash Flow-SGD 9M
Debt / Equity21%
Profitability & ownership
ROE-4.3%
ROA-3.0%
% insiders15.9%
% institutions1.9%
Last declaration on 10 May 2024
Declarations16 total
  • ●
    Director/CEOExecutives
    0SGX
    2,868,577 sharesShareSGX-STISIN BMG5958R1043SGX:OFEGGXIAL5WHGOZO
  • ●
    Director/CEOExecutives
    0SGX
    11,700,000 sharesShareSGX-STISIN BMG5958R1043SGX:QLLY74PR4N1A2I3C
  • ▲
    Director/CEOExecutives
    286,789 SGD30SGX
    500,000 shares@ SGD 0.5736100.0% of flowShareSGX-STISIN BMG5958R1043SGX:FJZ7N8QYRFRMDW0D
    Canonical exit: 18 Nov 2021 (T+90)
  • ▲
    Director/CEOExecutives
    420,272 SGD24SGX
    500,000 shares@ SGD 0.840516.0% of flowShareSGX-STISIN BMG5958R1043SGX:P9EAFKZPVF9FZ888
    Canonical exit: 22 Sept 2021 (T+90)
  • ▲
    Director/CEOExecutives
    479,000 SGD24SGX
    500,000 shares@ SGD 0.95818.1% of flowShareSGX-STISIN BMG5958R1043SGX:7KWIHCC43V5BPE14
    Canonical exit: 10 Aug 2021 (T+90)
  • ▲
    Director/CEOExecutives
    525,902 SGD24SGX
    500,000 shares@ SGD 1.051819.6% of flowShareSGX-STISIN BMG5958R1043SGX:99GFRIV2YOCIYWSH
    Canonical exit: 22 Mar 2021 (T+90)
  • ▲
    Director/CEOExecutives
    921,998 SGD26SGX
    1,000,000 shares@ SGD 0.92235.3% of flowShareSGX-STISIN BMG5958R1043SGX:DFN0N8KHEKCB9MAR
    Canonical exit: 16 Feb 2021 (T+90)
  • ▲
    Director/CEOExecutives
    13,500 SGD27SGX
    10,000 shares@ SGD 1.3547.4% of flowShareSGX-STISIN BMG5958R1043SGX:FAP8RR5UNKXTT7A1
    Canonical exit: 2 Dec 2020 (T+90)
  • ▲
    Director/CEOExecutives
    15,000 SGD27SGX
    10,000 shares@ SGD 1.5052.6% of flowShareSGX-STISIN BMG5958R1043SGX:PO18AINAKSJ62PYD
    Canonical exit: 11 Nov 2020 (T+90)
  • ▼
    Director/CEOExecutives
    309,230 SGD22SGX
    3,070,800 shares@ SGD 0.10072.9% of flowShareSGX-STISIN BMG5958R1043SGX:2AM9D7TDUBHN5ZV0
  • ▼
    Director/CEOExecutives
    922,636 SGD23SGX
    10,228,775 shares@ SGD 0.09028.5% of flowShareSGX-STISIN BMG5958R1043SGX:9WM5DTBNMDTSDB1Z
  • ▼
    Director/CEOExecutives
    1M SGD23SGX
    8,862,700 shares@ SGD 0.12049.9% of flowShareSGX-STISIN BMG5958R1043SGX:QKDRH48BV0762JPC
  • ▼
    Director/CEOExecutives
    3M SGD24SGX
    20,000,000 shares@ SGD 0.127323.6% of flowShareSGX-STISIN BMG5958R1043SGX:POAFJW4GYGSL8A19
  • ▼
    Substantial ShareholderExecutives(filed)
    3M SGD25SGX
    20,000,000 shares@ SGD 0.1273100.0% of flowShareSGX-STISIN BMG5958R1043SGX:PFHHC5XXW2OIZUKG
  • ▼
    Director/CEOExecutives
    3M SGD25SGX
    22,700,000 shares@ SGD 0.124226.3% of flowShareSGX-STISIN BMG5958R1043SGX:PJQ2GJNLLUQ8S3WY
  • ▼
    Director/CEOExecutives
    3M SGD25SGX
    17,000,000 shares@ SGD 0.18228.9% of flowShareSGX-STISIN BMG5958R1043SGX:ICNZI1YAD8HCJ4E7

16 of 16 declarations

About Medtecs International Corp Ltd

Medtecs International Corp Ltd is a company specializing in the provision of medical apparel and healthcare services. It primarily operates in the personal protective equipment and medical supplies sector.